| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |